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T here is an approximate growth of 3% to 4% of pa-tients undergoing dialysis every year as a result of
an increased pool of chronic kidney disease (CKD) from
variousmedical problems such asdiabetes, hypertension,
and cardiovascular diseases. Arteriovenous (AV) ﬁstula
use increased from 27.9% to 55%between 1998 and 2007
(Figure 1).1 By December 2013, in 62.5% of prevalent
dialysis patients an AV ﬁstula was being used.2 In 1966,
Brescia et al. introduced the endogenous AV ﬁstula, a
revolutionary therapeutic modality for the management
of renal patients.Most common complications of vascular
access can be divided into hemodynamic and mechanical
complications. Complications from hemodynamic alter-
ations include venous hypertension, arterial steal syn-
drome, and high-output cardiac failure. Mechanical
complications include pseudo-aneurysm, which may
develop from a puncture hematoma, degeneration of the
wall, or infection. A rare complication that can develop
after hemodynamic alteration of vascular access is
ischemic monomelic neuropathy (IMN).
CASE PRESENTATION
A 59-year-old African American man was admitted for
creation of vascular access for dialysis. Past medical his-
tory included diabetes mellitus complicated by periph-
eral neuropathy and retinopathy, end-stage renal disease
(ESRD) from diabetes and hypertension, a history of
dialysis for about 7 years, multiple deep venous throm-
boses in the upper extremities at AV ﬁstula sites, hy-
pertension, hyperlipidemia, chronic pancreatitis, anemia,
and previous smoking (half a pack per day for 20 years).Physical examination showed a temperature of
98 F, blood pressure 104/59 mm Hg, pulse 99 beats/min,
respiratory rate of 16/min, and 98% saturation on
room air. Extremities had bilateral edema 1þ. The
lower extremity pulses were difﬁcult to determine
because of the edema. The rest of the examination
ﬁndings were normal. Laboratory values on admission
were as follows: white blood cells 8.4, hemoglobin
10.4, platelets 274, and hematocrit 32. The basic
metabolic panel included sodium 134 mEq, potassium
4.3, chloride 98, bicarbonate 20, blood urea nitrogen
33, and creatinine 4.0 mg/dl. Liver function tests
include total protein is 8.8, albumin is 4.5, bilirubin
0.7, alkaline phosphate 269, AST 50, ALT 31. Coagu-
lation tests showed an international normalized ratio
(INR) of 1.2, prothrombin time (PT) 12.1 seconds, and
activated partial thromboplastin time (aPTT) 45.9
seconds.
Hospital Course
The patient was started on heparin for bridging anti-
coagulation, as INR was subtherapeutic. He had a right
femoral catheter for regular dialysis. After great
saphenous vein mapping was performed, the patient
underwent a left superﬁcial femoral artery to vein loop
graft without any perioperative complications. On
postoperative day 0, the patient complained of pain at
the incision site and weakness of left lower extremity.
His pain was controlled with acetaminophen/oxyco-
done, and it was thought that his weakness could be
from surgery or anesthetics or from his posture. On
postoperative day 1, he complained of worsening
weakness and numbness of left lower extremity.Kidney International Reports (2017) 2, 76–79
Figure 1. Arteriovenous (AV) ﬁstula usage.
Figure 2. Ankle-brachial index (ABI) before and after graph place-
ment. AVF, arterio-vascular ﬁstula; AVG, arterio-vascular graft.
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time. On examination the patient had edema at the
incision site, and the leg was warm to the touch.
Neurological examination showed normal mental sta-
tus, speech, language, and cranial nerves. The motor
system showed normal bilateral upper extremity
strength. The lower extremities showed left foot dor-
siﬂexion of 1/5, left foot plantar ﬂexion 3/5, and right
dorsiﬂexion and plantar ﬂexion of foot 5/5. Left hip
ﬂexion was 3/5 when the patient was lying on the bed
and was 1/5 when he was sitting on the bed. The foot
invertors were 0/5 and the foot evertors 0/5. Sensation
to light touch, cold, pinprick, and temperature were
decreased on the left from the lower third of the leg to
the foot and were normal on the right side. Sensation to
light touch and cold were normal on the right side.
Coordination test results were normal. Pulses could not
be determined because of chronic edema.
Ultrasound of the left thigh, computed tomography
of the abdomen and pelvis, and magnetic resonance
imaging of the spine did not explain the causes of the
above-mentioned clinical ﬁndings. Ultrasound showed
a patent AV graft and no hematoma. The ankle-brachial
index (ABI) was 0.93 on the right and 0.67 on the left,
and decreased on the left side following graft place-
ment. The ABI before placing the AV graft was 0.93 in
both legs (Figure 2). Current analog tracings were
consistent with tibial obstructive disease on the left.
The right leg was normal. Physical therapy was
brought on board, as well as assistance with ambula-
tion, and the patient was found to have a high stepping
gait on the left. Vitamin D levels were normal. Foot
drop and weakness after surgery without lumbar rad-
iculopathy pointed to ischemic monomelic neuropathy
(IMN), which was a diagnosis of exclusion.
After diagnosing IMN clinically, we evaluated the
patient’s risks and beneﬁts of closing versus not closing
the AV graft. He did not have any other site for
creating another AV access for dialysis, and closing theKidney International Reports (2017) 2, 76–79AV graft would not completely resolve the problem.
We planned to manage the foot drop by physical
therapy and anklefoot arthrosis. The patient’s
ambulatory status was somewhat impaired due to
arthritis and general medical decline for some months
prior to the vascular access surgery. He and his family
agreed with conservative management and decided not
to close AV graft. He was discharged with follow-up
neurology consultation for electromyography to eval-
uate the extent of damage, and also followed up with
vascular surgery for assessing the AV graft.
DISCUSSION
Our patient had neurological symptoms conﬁned to the
left lower extremity, weakness, and a foot drop
complication. The differentials were IMN, lumbar
plexopathy, nerve compression by hematoma or by
edema, spinal cord pathology, and iatrogenic nerve
injury.
Ultrasound, computed tomography of the abdomen
and pelvis, and magnetic resonance imaging of the
spine ruled out any of above differential diagnoses. The
ABI were done before and after surgery and clearly
showed decreased ABI on left after surgery, which was
due to a physiological steal phenomenon. The patient
did not have vascular ischemic symptoms. The recent
vascular access surgery and neurological symptoms of
foot drop, numbness, and weakness were suggestive of
nerve damage at the level of the mid-thigh or leg or
both. As there was no nerve compression, the most
likely possibility was IMN.
Ischemic neuropathy of upper limb nerves after
dialysis surgery was ﬁrst reported by Bolton et al. in
1979.3 The term “ischemic monomelic neuropathy” was
introduced in 1983 by Wilbourn, a neurologist at the
Cleveland Clinic, and was intended to distinguish iso-
lated ischemia of the arterial supply from multiple
nerves of a single extremity.4 The term refers to the
combination of ischemia and neuropathy in a single77
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deﬁned IMN as a type of multiple axonal-loss mono-
neuropathy distally in a limb, resulting from an
impaired blood supply after graft insertion. It is an
underappreciated complication because of its variable
manifestations in the postoperative period, and is
difﬁcult to diagnose with underlying comorbidities. It
requires a high index of suspicion and multidisci-
plinary involvement to diagnose promptly and manage.
Most cases are in patients with underlying diabetes
with peripheral complications. There are few cases seen
in patients with severe vascular extensive calciﬁc dis-
ease. This complication occurs with the steal phenom-
enon, which is a diversion of blood supply away from
the peripheral. It is unusual to expect this complication
presenting with neurological injury rather than
vascular injury. This leads to both short- and long-term
disability. Miles described IMN symptoms as being
immediate in onset, with dominant neurologic signs
and symptoms.5 In general, sensory complaints are
more prominent than motor.
Some authors consider IMN to be result of dialysis-
associated steal syndrome (DASS), not involving mus-
cles; thus it could be a condition on the spectrum of
DASS rather than a different entity. In DASS, there will
be peripheral muscle or skin ischemia as a typical
feature. Both conditions have a common pathophysi-
ology: that is, they occur as a result of ischemia.
Recently, the Vascular Access Society has suggested
using the phrase dialysis access–induced ischemic
syndrome (DAIIS) instead of steal syndrome, which
includes IMN in the spectrum.
A greater global awareness among the multidisci-
plinary team, which often includes internists, neurol-
ogists, nephrologists, vascular surgeons, interventional
radiologists, nurses, and dialysis care technicians, is
necessary to advocate for the early consideration of
IMN.
Pathophysiology
The exact mechanism of IMN is poorly understood.
IMN is a form of steal phenomenon, as the access sur-
gery “steals” blood ﬂow from distal nerve tissue,
causing multiple axonal loss mononeuropathies distally
in the limb. So far, we have seen cases in the upper
extremities. Kelly et al. demonstrated, with electron
microscopy, decreased perfusion of the vasa nervorum
after acute large vessel ligation in their experiment
model.6
In the upper extremities, the median nerve shows a
greater susceptibility to ischemic injury, based on the
ﬁnding of greater axonal loss in the median as
compared with the ulnar nerves. Physiologically there
is diversion of some amount of blood away from distal78vessels to the ﬁstula or graft; if it large enough to cause
ischemia, then we might see this complication. If sur-
gery is proximal, the chance of having this complica-
tion is great. Nerves are susceptible to ischemia owing
to the lack of a collateral supply. The sensory ﬁbers are
more sensitive to ischemic insult than are the motor
ﬁbers.
Diagnosis
This condition is a clinical diagnosis. It should be
associated with artery manipulation with underlying
peripheral neuropathy and peripheral artery disease. It
is a distinct diagnosis that occurs in the setting of mild
to moderate ischemia.7 The symptoms most commonly
occur immediately postoperatively, and the nerve
deﬁcits are disproportional to any ischemic changes
seen in other tissues of the affected limb.7 The most
commonly reported location is from the brachial artery
manipulation. This is the ﬁrst report of a case from the
left femoral artery manipulation.
When the clinical neurologic examination results are
equivocal, electro-diagnostic studies may facilitate
diagnosis.8 Electromyography and nerve conduction
studies can be used to conﬁrm the diagnosis. The
electromyogram typically shows axonal loss, low
amplitude or absent responses to the sensory and motor
nerve stimulation, and relatively preserved conduction
velocities. For our case, we were able to make the
diagnosis clinically with the help of neurologists, and
no decision was made to do repeat electromyography
conﬁrming IMN.
Incidence
Because diagnosis of IMN requires a multidisciplinary
approach, it is assumed that there are underdiagnoses
and underreporting. Lack of experience and equivocal
symptoms may be the reasons for the paucity of reports
of IMN, most of which were not published before the
end of the 1990s. Two reports suggested incidences
around 0.5% or 3%.9
Treatment
A patient complaining of neurological symptoms
postoperatively after AV procedures should have a
neurology consultation for early diagnosis and man-
agement. So far, treatment has been based on case re-
ports and expert opinion. Treatment recommendations
are derived from observational data. Theoretically, if
we reduce the ﬂow in the AV graft or shunt leads, it
will cause increased perfusion in the extremities and
will reduce the neuropathy. Most authors prefer he-
modialysis access closure by ligation, banding, or an-
gioplasty as an option to improve blood ﬂow to the
extremities.Kidney International Reports (2017) 2, 76–79
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that blood supply back to the periphery may lead to
recovery, but actual scenarios have shown inconclusive
results. According to one study that involved 19 cases,
10 patients were not improved even after correction
of hemodialysis access.10 However, even if surgical
correction of the shunt is performed within a short
time, symptoms may be only slightly or even not at all
improved. Despite attempts at earlier closure, several
published reports suggest that even with this aggres-
sive management, IMN symptoms may be permanent
or only partially reversible.11 As a practical matter,
many patients may have few alternative sites or none
(as in our patient) for future hemodialysis access
construction.
The decision to close a functioning access requires
careful deliberation. This complication can occur in
other sites, given that the underlying risk factors are
unchanged. As it is nerve injury, cases have shown
poor prognoses despite access closure. Most patients
will be left with residual neurologic impairment.
Further treatment for IMN is mainly supportive and
should include pain control. Anticonvulsants, anti-
depressants, and narcotics have been suggested for
pain control.12 Hand ischemia from arterial steal
should be treated with a distal revascularization in-
ternal ligation procedure. If this fails or is not feasible,
ligation of the AV ﬁstula or graft should be consid-
ered. This is a grade D recommendation from a
vascular surgery board. Despite our limited experi-
ence, there seems to be no doubt that any time delay
plays a major role in the prognosis of IMN. Accord-
ingly, immediate diagnosis means more time for
adequate treatment.
CONCLUSION
In conclusion, IMN is not conﬁned to the upper ex-
tremities. All health care practitioners taking care of
ESRD patients undergoing vascular access procedures
should be aware of this complication. Suspicion
and recognition are very important. This complication
is less associated with tissue ischemia. Every case
of IMN should be carefully documented and, if
possible, published so as to gain more experience with
pathophysiology and treatment. Considering all theKidney International Reports (2017) 2, 76–79risks and beneﬁts of vascular access closure or non-
closure, choosing wise management is crucial. We will
see more cases in the future, as there are a growing
number of ESRD patients requiring vascular access for
dialysis. IMN is a difﬁcult diagnosis, because of the
inconsistency of the clinical signs and the occurrence
in the immediately postoperative period.DISCLOSURE
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